A detailed history of Key F Inancial Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Key F Inancial Inc holds 426 shares of MRNA stock, worth $28,009. This represents 0.01% of its overall portfolio holdings.

Number of Shares
426
Previous 426 -0.0%
Holding current value
$28,009
Previous $45,000 11.11%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$69.51 - $104.43 $17,377 - $26,107
-250 Reduced 36.98%
426 $42,000
Q3 2023

Nov 01, 2023

SELL
$96.41 - $126.61 $2,313 - $3,038
-24 Reduced 3.43%
676 $69,000
Q2 2023

Jul 28, 2023

SELL
$118.5 - $160.53 $118 - $160
-1 Reduced 0.14%
700 $85,000
Q1 2023

May 02, 2023

BUY
$135.66 - $197.02 $23,876 - $34,675
176 Added 33.52%
701 $107,000
Q3 2022

Oct 28, 2022

BUY
$118.07 - $194.18 $44,276 - $72,817
375 Added 250.0%
525 $62,000
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $33,873 - $55,276
150 New
150 $38,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.